Grief Support for Addiction and Overdose Losses
Grief is the normal and natural reaction to any significant loss, whether that is a bereavement loss or a non-death loss. Family members of those with substance use disorders often experience deep ambiguous loss, a type of grief often misunderstood by professionals and can prove incredibly complex for families. The first half of this is designed to understand and provide strategies for families grieving loved ones who are living with substance use disorders.
The second half of this program will assist professionals in responding to the unique grief following a substance-related death. Over...Read moredose deaths hit 107,000 in 2021, a record in the US and an increase of nearly 20% over the previous annual high. Unfortunately, research and support around this type of loss remain limited. This session will provide strategies for supporting those dealing with the most common complex issues of substance-related grief, including disenfranchised grief, guilt, blame, relief, and introducing basic coping tools for individuals and support systems. Less...
- Define grief and explore the impact of grief both before and after a death to overdose or other substance-related cause.
- Identify key indicators of ambiguous grief and introduce therapeutic and psychoeducational interventions to ease the stress of ambiguous loss for families with loved one(s) with substance use disorders.
- Articulate common modern grief theories in contrast to the traditional stage mode of grief and their applications in cases of addiction and overdose.
- Describe the unique aspects of the disenfranchised grief experience of family members and friends who have lost a loved one to addiction.
- Apply evidence-informed principles of grief support to family members of those experiencing grief following a substance use death.
Thursday, August 31, 2023
01:00 PM EDT - 04:15 PM EDTRegister for this Webinar
Click Here to Register
About the speakers
Litsa Williams MA, LCSW-C
Eleanor Haley, MS
1:00-1:30 Introduction, data review, and defining grief
- Doka and the introduction of the grief beyond bereavement loss.
1:30-2:30 Grief and Addiction: Understanding Non-Death Loss
- Defining the two types of ambiguous loss
- Relational stress and assessing the impact of ambiguous loss
- Family Systems
2:45-3:15 Grief and Overdose Loss: Understanding Disenfranchised Grief
- Defining disenfranchised loss
- The role of support systems and subjectivity
- The impact of disenfranchised losses on grief
3:15-4:00 Common Grief Experiences and Interventions
- Those unaware of a substance use disorder
- Those aware of a substance use disorder
- Friends and family also abusing substances.
4:00-4:05 Locating Community Resources
4:05-4:15 Questions and Close
CE Information - Earn 3 CE Credit Hours
American Psychological Association
New York State Education Department's State Board for Social Work
New York Education Department Board of Creative Arts Therapy
New York Education Department for Licensed Mental Health Counselors
Maryland Board of Social Work Examiners
New York State Education Department's State Board for Psychology
New York State Education Department's State Board for Marriage and Family Therapy
CE Process Info
Each professional is responsible for the individual requirements as stipulated by his/her licensing agency. Please contact your individual licensing board/regulatory agency to review continuing education requirements for licensure renewal. Please note: You must attend "live" (in real-time) to earn CE credits.
Before the event, you will receive an email from CE-Go with access to the virtual event. After the event, you will receive access to your evaluation and continuing education certificate via a personalized "attendee dashboard" link, hosted on the CE-Go website. This link and access to the virtual event will be sent to the email account you used to register for the event.
Upon accessing the CE-Go "attendee dashboard", you will be able to:
- Complete evaluation forms for the event
- Download your continuing education certificate in a PDF format
If you have any questions or concerns regarding the CE-Go platform, please contact CE-Go at 888-498-5578 or by email at firstname.lastname@example.org Please Note: Emails for this event will come from "email@example.com".
If you have any continuing education related questions, please contact your event organizer.
Please make sure to check your spam/junk folder in case those emails get "stuck". We'd also suggest "Allowlisting" firstname.lastname@example.org. This tells your email client that you know this sender and trust them, which will keep emails from this contact at the top of your inbox and out of the junk folder.
DisclosureDISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
CE Learning Systems, LLC is an independent provider of continuing medical education. CE Learning Systems, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, CE Learning Systems, LLC is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest).
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
2. any investigational, off-label, or non-FDA approved content or discussion
CE Learning Systems, LLC has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
1. All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
The faculty have reported the following: There are no relevant disclosures.
The planners have reported the following: There are no relevant disclosures.